'Right To Try' And PDUFA VI: Patient Advocates, Industry Fight Senate Add-On

Given that 'right to try' is intended to be a patient-centered proposal, patient organizations are a strong voice in opposition, working behind the scenes to revise – or entirely exclude – the legislation as part of the user fee package. But the bill also has powerful advocates among Senate Republicans and in the Trump Administration.

Capitol House

Patient advocates are working with Congressional staff to revise proposed federal “Right to Try” legislation that would prohibit the US FDA from taking any action to restrict compassionate use programs in the 34 states that allow it.

Opponents to the measure – including Friends of Cancer Research, the American Cancer Society and the National Organization for Rare...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Legislation

More from Pink Sheet